Arkolith/Insider Trading/SMMT/Form 4

Dhingra Ankur

Chief Financial OfficerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Mar 27, 2024
Net Buying
Open-Market Buys
$375K
Open-Market Sells
$0
Net Open-Market Flow
$375K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2024Buy(P)100K$3.75$375K355K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-24-000046) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML